Aptus Pharma Limited Hits Lower Circuit on BSE, 28 October 2026

Price bands decide how far a stock can fall in a session, and the Aptus Pharma lower circuit on 28 October 2026 shows that limit being reached. Aptus Pharma Limited (APPL) was locked on BSE at Rs 462.7, 1.99% under the previous close of Rs 472.1, with a market cap of Rs 809.65 crore.

A stock sitting at its floor cannot trade lower that day, so the pressure shows up as unfilled sell orders rather than as further price movement. That makes the session relevant mainly to short-term traders.

Key Takeaways

• Aptus Pharma Limited (APPL) hit the lower circuit on BSE at Rs 462.7 on 28 October 2026.
• The session move was -1.99% against a previous close of Rs 472.1.
• Market capitalisation stood at Rs 809.65 crore with a PE ratio of 175.25.
• No official company announcement or verified catalyst was confirmed at the time of writing.
• A price band is an exchange trading rule, not a view on the company or a recommendation.

Key Market Data

All figures above are as of 28 October 2026, sourced from Univest market data for the BSE listing. Only fields present in the source for this session are shown.

Price Action and Trading Activity

Aptus Pharma Limited opened at Rs 462.7 and never left that price. The open, high and low all matched the band level, which means the stock began the session at the floor and stayed pinned there, against a previous close of Rs 472.1.

The drop from the previous close was Rs 9.4, or 1.99%. All numbers are taken from BSE, so the open, the day range and the reference close are directly comparable.

Exchanges can set different bands and record different reference prices, so this narrative and the table beside it use BSE data from start to finish. The session floor was Rs 462.7.

Why Aptus Pharma Limited Hit Lower Circuit

Selling pressure carried Aptus Pharma Limited down to its exchange-defined price band, which is as much as the record supports. Neither a company announcement nor a verified outside catalyst was confirmed at the time of writing, so the move is best described as price action and sentiment.

Because no trigger has been verified, this note does not blame results, corporate action, sector news or market talk for the fall. Any confirmed disclosure that emerges later would be handled in a separate update.

The stock reached Rs 462.7 in the session.

What the Aptus Pharma Lower Circuit Means

The price band caps how far a stock may move in one trading day, and the lower circuit is its downside edge. For Aptus Pharma Limited, that edge stood at Rs 462.7 on 28 October 2026.

Bands exist to slow abrupt moves and keep trading in order. They describe how the market is structured and carry no forecast for returns. Here, the circuit marks where the session’s price band was reached, and the next session is measured from a fresh reference price.

Aptus Pharma Limited Fundamentals and Valuation

Market data fills in the picture that price alone leaves out. Aptus Pharma Limited had a PE ratio of 175.25 and a PB ratio of 24.07, with a book value of Rs 19.61 per share, EPS of 2.69 and a market cap of Rs 809.65 crore. These figures describe the company and are not a buy, sell or hold view.

A PB ratio of 24.07 shows the market valuing the company far above its reported book value per share. A premium like that can reflect growth hopes, asset quality, or thin trading in a small counter.

For readers following lower circuit moves, such ratios keep the price event apart from the broader financial profile. A sharp session draws the eye, but valuation and profitability each need a separate look.

Peer and Sector Context

Aptus Pharma Limited belongs to the Trading industry. The peer table below uses available companies from the same sector or industry to give broader valuation context.

Aptus Pharma Limited’s PE ratio was 175.25, compared with an available peer PE average of 75.71, calculated from the 5 peer companies that had a PE on record. This comparison is a valuation reference point, not a recommendation.

Technical Snapshot

The technical snapshot adds context: RSI was 74.84, the 50-day moving average was 413.53 and the 200-day moving average was 287.56.

Worth flagging: the RSI reading sits on the opposite side of neutral to the day move and the last traded price and the 50-day average point in different directions. Indicator values in the dataset can lag the live session, so they should be checked against a live chart before being relied on.

What Readers Should Know

Only a few facts are firm: Aptus Pharma Limited was locked at the lower circuit on BSE at Rs 462.7 on 28 October 2026, a move of 1.99% from the previous close.

Execution is the practical difficulty. With sellers lined up at the band and buyers thin, an exit at the quoted price may not be achievable. A second limit is that no official catalyst had been confirmed when this was written.

Treat the event as a market update and not a conclusion in itself. It reflects heavy selling at present, and deeper work should look at business fundamentals, valuation, liquidity, risk and confirmed company disclosures.

Frequently Asked Questions

Why did Aptus Pharma Limited hit lower circuit on 28 October 2026?

The stock reached its lower price band after selling pressure during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.

What was APPL share price on 28 October 2026?

The last traded price used in this article was Rs 462.7 on BSE. That price matched the lower circuit price captured for the event.

What was the lower circuit price for APPL?

The lower circuit price was Rs 462.7. The stated exchange lower circuit limit was Rs 462.7. The event numbers in this article are aligned to BSE.

What is Aptus Pharma Limited’s market cap and PE ratio?

Aptus Pharma Limited’s market cap was Rs 809.65 crore. PE ratio was 175.25.

Which exchange and data source were used?

The selected exchange was BSE. The article uses Univest market data available at the time of generation, captured on 28 October 2026.

Does hitting a lower circuit mean Aptus Pharma Limited is a buy or a sell?

No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.

Can you buy or sell Aptus Pharma Limited shares when the stock is at the lower circuit?

It is usually difficult. At the lower circuit, sell orders queue up with few buyers, so exiting at the quoted price may not be possible. Orders can stay unfilled until buying interest returns.

What happens the next trading session after a lower circuit?

There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.

What is the lower circuit limit set at for Indian stocks?

Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For Aptus Pharma Limited the stated limit was Rs 462.7. For this session, Aptus Pharma Limited moved -1.99%.